AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune ...

Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform ...

As part of the collaboration, the drugmaker will use Immunai's AI model of the immune system and machine learning for ...

AstraZeneca is extending its work with Immunai through a multiyear collaboration that aims to implement its ...

Immunai already has strategic agreements with 30 pharmaceuticals companies, most of them involving much smaller financial ...

The event also marked the official dedication of the Adele and Joel Sandberg Women's Unit. Information ...